Biocon Q2: Cons Net Profit At Rs 102.1 Cr Vs Poll Of Rs 92.5 Cr
Biocon Q2: Cons Revenue At Rs 740.8 Cr Vs Poll Of Rs 718 Cr
Biocon Q2: Cons EBITDA At Rs 176 Cr Vs Poll Of Rs 152.6 Cr
Biocon Q2: Cons Operating Margin At 23.7% Vs Poll Of 21.3%
I HAD CLEARLY TOLD TO GO LONG ON THE STOCK AT 305 WHEN IT BROKE OUT
AND STOCK HIT 330
AGAIN GAVE CALL TO BUY ABV 330 WHEN IT BROKE OUT AND STOCK HIT 360 LEVELS
NOW AGIAN IAM FEELING BULLISH ON THE STOCK ABV 342 ON CLOSING BASIS SL 335 ON CLOSING BASIS FOR 360-365 LEVELS IN SHORT TO MEDIUM TERM